Release Date: 19/04/17 08:31 Summary: CHP Delivers Strong FY 2016 Results - Poised for Growth Price Sensitive: No Download Document 638.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%